5oje
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5oje is ON HOLD Authors: Description: Category: Unreleased Structures) |
|||
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Endothiapepsin with Ligand VSK-B24== | |
+ | <StructureSection load='5oje' size='340' side='right'caption='[[5oje]], [[Resolution|resolution]] 1.58Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5oje]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Cryphonectria_parasitica Cryphonectria parasitica]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5OJE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5OJE FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.579Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=VSK:(2~{S})-2-azanyl-3-(1~{H}-indol-3-yl)-~{N}-[2-(2,4,6-trimethylphenyl)ethyl]propanamide'>VSK</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5oje FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5oje OCA], [https://pdbe.org/5oje PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5oje RCSB], [https://www.ebi.ac.uk/pdbsum/5oje PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5oje ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/CARP_CRYPA CARP_CRYPA] | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Acylhydrazone-based dynamic combinatorial chemistry (DCC) is a powerful strategy for the rapid identification of novel hits. Even though acylhydrazones are important structural motifs in medicinal chemistry, their further progression in development may be hampered by major instability and toxicity issues under physiological conditions. It is therefore of paramount importance to identify stable replacements for acylhydrazone linkers. Here, we present the first report on the design and synthesis of stable bioisosteres of acylhydrazone-based inhibitors of the aspartic protease endothiapepsin as a follow-up to a DCC study. The most successful bioisostere is equipotent, bears an amide linker and we confirmed its binding mode by X-ray crystallography. Having some validated bioisosteres of acylhydrazones readily available might accelerate hit-to-lead optimization for future acylhydrazone-based DCC projects. | ||
- | + | Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin.,Hirsch AKH, Jumde VR, Mondal M, Gierse RM, Unver MY, Magari F, van Lier RCW, Heine A, Klebe G ChemMedChem. 2018 Sep 3. doi: 10.1002/cmdc.201800446. PMID:30178575<ref>PMID:30178575</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
+ | <div class="pdbe-citations 5oje" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Pepsin|Pepsin]] | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Cryphonectria parasitica]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Gierse RM]] | ||
+ | [[Category: Groves MR]] | ||
+ | [[Category: Heine A]] | ||
+ | [[Category: Hirsch A]] | ||
+ | [[Category: Klebe G]] | ||
+ | [[Category: Magari F]] |
Current revision
Endothiapepsin with Ligand VSK-B24
|